Plasma levels of glucagon‐like peptide 1 and markers of obesity among young and healthy adults

E-ISSN： 1365-2265|83|5|636-642

ISSN： 0300-0664

Source： CLINICAL ENDOCRINOLOGY, Vol.83, Iss.5, 2015-11, pp. : 636-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Overnight hypoxic exposure and glucagon-like peptide-1 and leptin levels in humans

By Snyder Eric M. Carr Richard D. Deacon Carolyn F. Johnson Bruce D.

Applied Physiology, Nutrition, and Metabolism, Vol. 33, Iss. 5, 2008-10 ,pp. : 929-935

NRC Research Press

Access to resources Recommend Favorite

Effects of gastric inhibitory polypeptide, glucagon‐like peptide‐1 and glucagon‐like peptide‐1 receptor agonists on Bone Cell Metabolism

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 122, Iss. 1, 2018-01 ,pp. : 25-37

John Wiley & Sons Inc

Access to resources Recommend Favorite

GSK2374697, a long duration glucagon‐like peptide‐1 (GLP‐1) receptor agonist, reduces postprandial circulating endogenous total GLP‐1 and peptide YY in healthy subjects

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 1462-8902, Iss. 10, 2015-10 ,pp. : 1007-1010

John Wiley & Sons Inc

Access to resources Recommend Favorite

GSK2374697, a long duration glucagon‐like peptide‐1 (GLP‐1) receptor agonist, reduces postprandial circulating endogenous total GLP‐1 and peptide YY in healthy subjects

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 10, 2015-10 ,pp. : 1007-1010

John Wiley & Sons Inc

Access to resources Recommend Favorite

Weight loss effect of glucagon‐like peptide‐1 mimetics on obese/overweight adults without diabetes: A systematic review and meta‐analysis of randomized controlled trials胰高血糖素样肽‐1类似物对非糖尿病肥胖/超重成人的减重作用：一篇对随机对照试验进行的系统评价及meta分析

JOURNAL OF DIABETES, Vol. 7, Iss. 3, 2015-05 ,pp. : 329-339

John Wiley & Sons Inc

Access to resources Recommend Favorite